Dolby Family Ventures
Dolby Family Ventures is an early stage venture firm focused on building great technology companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Dolby Family Ventures Information
Geographic Data
Address: 999 Brannan St
City: San Francisco
State: CA
Zip: 94103
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Dolby Family Ventures is an early stage venture firm focused on building great technology companies. They partner with best-in-class innovators and strong investment syndicate partners at the seed stage of a company’s development. Unlike many seed investors, They intend to continue to invest across future rounds in our successful portfolio companies.
Contact Phone:
+14154491005
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 6/2018 | Zebra Medical Vision | Series C | 30M |
| 2/2015 | Mixed Dimensions | Convertible Note | 0 |
| 10/2020 | Sea Machines Robotics | Series B | 0 |
| 6/2018 | Vium | Series B | 24M |
| 11/2017 | Athira Pharma | Venture Round | 15.2M |
| 12/2021 | Ursa Major | Series C | 85M |
| 6/2015 | Eargo | Series A | 13.6M |
| 9/2015 | Cognition Therapeutics | Series B | 0 |
| 6/2014 | Wickr | Series B | 0 |
| 7/2019 | Strateos | Venture Round | 0 |
| 9/2020 | Neuro Therapia | Series A | 0 |
| 12/2014 | 3Scan | Series A | 6.7M |
| 6/2014 | Authentic Vision | Venture Round | - |
| 11/2015 | Stellar Labs | Seed Round | 0 |
| 8/2010 | ZOZI | Series A | 3M |
| 5/2016 | Zebra Medical Vision | Series B | 12M |
| 10/2020 | Authentic Vision | Series B | 5M |
| 5/2021 | Therini Bio | Seed Round | 0 |
| 5/2020 | QurAlis | Series A | 0 |
| 2/2020 | EnClear Therapies | Series A | 0 |
| 7/2019 | Therini Bio | Seed Round | 9.3M |
| 5/2023 | Genemod | Seed Round | 0 |
| 1/2021 | CytoVale | Debt Financing | 0 |
| 6/2019 | Lightform | Series A | 0 |
| 10/2013 | BASIS Science | Series B | 23M |
| 10/2014 | Keyssa | Series C | 25M |
| 2/2019 | Phylagen | Series A | 0 |
| 5/2018 | Phase Four | Seed Round | - |
| 10/2017 | Stellar Labs | Series A | 0 |
| 8/2017 | Tempo Automation | Series B | 20M |
| 11/2013 | August Home | Series A | 8M |
| 1/2015 | goBalto | Series C | 0 |
| 7/2021 | H2U Technologies | Series A | 7M |
| 11/2016 | Tetra Therapeutics | Series A | 0 |
| 10/2021 | H2U Technologies | Series A | 0 |
| 7/2015 | AltspaceVR | Series A | 10.3M |
| 11/2022 | Cajal Neuroscience | Series A | 96M |
| 1/2023 | Atomos Space | Series A | 16.2M |
| 2/2016 | Yumanity Therapeutics | Series A | 51M |
| 5/2017 | Ultraleap | Series B | 23M |
| 2/2023 | Cerevance | Series B | 0 |
| 4/2023 | Therini Bio | Series A | 0 |
| 3/2017 | Echo | Series A | 7.5M |
| 8/2017 | Mixed Dimensions | Seed Round | 2.6M |
| 9/2016 | Podium Data | Series A | 9.7M |
| 4/2023 | Mojo Vision | Series C | 0 |
| 3/2023 | QurAlis | Series B | 0 |
| 6/2018 | Paradromics | Seed Round | 7M |
| 7/2021 | Paradromics | Seed | 20M |
| 3/2021 | TripleBlind | Seed Round | 0 |
| 10/2021 | TripleBlind | Series A | 24M |
| 4/2020 | Mojo Vision | Series B | 0 |
| 11/2021 | Cala Health | Series D | 0 |
| 7/2022 | Canaery | Seed Round | 0 |
| 6/2022 | OKAPI:Orbits | Seed Round | 0 |
| 1/2017 | DigiLens | Series B | 22M |
| 5/2018 | Cortexyme | Series B | 76M |
| 9/2020 | Libra Therapeutics | Series A | 29M |
| 1/2022 | Mojo Vision | Series B | 0 |
| 11/2018 | Mojo Vision | Series A | 0 |
| 4/2017 | Cortexyme | Debt Financing | 8M |
| 12/2015 | Eargo | Series B | 25M |
| 8/2020 | Atomwise | Series B | 0 |
| 7/2016 | 3Scan | Series B | 14M |
| 6/2015 | Vium | Series A | 20M |
| 5/2023 | Paradromics | Series A | 0 |
| 2/2022 | Diamond Age | Series A | 50M |
| 9/2018 | System1 Biosciences | Series A | 25M |
| 7/2015 | ZOZI | Series C | 0 |
| 9/2020 | NativeWaves | Seed Round | - |
| 4/2019 | NativeWaves | Seed Round | - |
| 4/2017 | Athira Pharma | Venture Round | 1.4M |
| 6/2014 | CytoVale | Series A | 4.3M |
| 2/2015 | New Matter | Series A | 6.5M |
| 10/2014 | Cortexyme | Seed Round | 1M |
| 11/2017 | Lightform | Seed Round | 0 |
| 12/2014 | Beep Networks | Seed Round | 4M |
| 9/2019 | GenomSys | Series A | 9.4M |
| 9/2021 | Acrigen Biosciences | Seed Round | - |
| 6/2011 | ICON Aircraft | Series C | 25M |
| 3/2018 | Atomwise | Series A | 45M |
| 2/2016 | Athira Pharma | Series A | 10M |
| 8/2008 | ZOZI | Seed Round | 1.3M |
| 11/2015 | Eyefluence | Series B | 14M |
| 3/2011 | ZOZI | Series B | 10M |
| 8/2021 | Diamond Age | Seed Round | 0 |
| 11/2022 | Bionaut Labs | Series B | 0 |
| 3/2019 | Kuprion | Series A | 5M |
| 10/2017 | Chirp Microsystems | Seed Round | 500k |
| 4/2022 | DigiLens | Series D | 0 |
| 12/2019 | Atmosic | Series B | 28.5M |
| 2/2021 | Roviero | Seed | 6.6M |
| 9/2021 | Delix Therapeutics | Series A | 0 |
| 9/2013 | Littlecast | Seed Round | 2M |
| 1/2018 | Tiaki Therapeutics | Seed Round | - |
| 1/2016 | Cortexyme | Series A | 15M |
| 12/2018 | Ultraleap | Series C | 0 |
| 11/2022 | MedCrypt | Series B | 0 |
| 5/2022 | Ubotica | Seed Round | 0 |
| 8/2017 | Alzeca Biosciences | Series A | 11M |
| 11/2015 | PharmatrophiX | Debt Financing | 10.3M |
| 11/2017 | Envisagenics | Seed Round | 2.4M |
| 4/2020 | Cerevance | Series B | 65M |
| 6/2012 | Tetra Discovery | Grant | 1.5M |
| 11/2017 | Ursa Major | Series A | 8M |
| 11/2021 | Sepion Technologies | Series A | 0 |
| 11/2021 | DigiLens | Series D | - |
| 7/2015 | Cognition Therapeutics | Series B | 15.8M |
| 7/2022 | Canaery | Seed Round | 0 |
| 6/2022 | OKAPI:Orbits | Seed Round | 0 |
| 5/2022 | Ubotica | Seed Round | 0 |
| 4/2022 | DigiLens | Series D | 0 |
| 2/2022 | Diamond Age | Series A | 0 |
| 1/2022 | Mojo Vision | Series B | 0 |
| 12/2021 | Ursa Major | Series C | 0 |
| 11/2021 | Sepion Technologies | Series A | 0 |
| 11/2021 | Cala Health | Series D | 0 |
| 11/2021 | DigiLens | Series D | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
